Europe's Covid surge looks less deadly as rise in testing keeps deaths low

Many of the infections stem from younger people traveling and partying during the summer holidays, and some of those cases have been asymptomatic

Coronavirus, vaccine, covid, drugs, clinical trials
Speedy drug trials could be partly responsible for the death toll remaining in check, with therapeutics like the low-cost, anti-inflammatory dexamethasone found to reduce the mortality of severely ill Covid-19 patients.
Suzi Ring | Bloomberg
3 min read Last Updated : Aug 23 2020 | 12:36 PM IST
Coronavirus infections are surging again in Europe, but current data indicate the outbreak is becoming less deadly.

Increased testing is catching the disease earlier, and in contrast to spikes in March and April -- when the pandemic ripped through nursing homes -- authorities are doing a better job of protecting the elderly and other vulnerable people, according to scientists.

France and Spain both recorded the highest numbers of new cases since April in the past week, while Italy reported its largest increase since May and Germany’s daily rates have doubled in recent weeks.

Yet as the contagion spreads again across the continent, fatalities are rising less dramatically -- at least for now.


“Improved access to testing is likely to be the main reason, especially as people become more aware of the symptoms,” said John Ford, a lecturer in public health at the University of Cambridge.

Many of the infections stem from younger people traveling and partying during the summer holidays, and some of those cases have been asymptomatic. Better treatment of the disease and improved procedures for identifying Covid-related deaths also help lower the death toll, Ford said.

With European countries gradually re-opening their economies, including greenlighting travel in mid-June, officials have been bracing for a surge as more people come into contact again. But after economies were decimated from lockdowns, they’re loath to revive stringent restrictions on activity.


 
German Chancellor Angela Merkel, who won plaudits for her handling of the initial phases of the pandemic, advised her peers to avoid renewed lockdowns and coordinate actions. The focus instead is on targeted measures such as stepping up the use of face masks, restricting operations of bars and restaurants and requiring travelers returning from hard-hit areas to quarantine or prove they’re not infected.

Speedy drug trials could be partly responsible for the death toll remaining in check, with therapeutics like the low-cost, anti-inflammatory dexamethasone found to reduce the mortality of severely ill Covid-19 patients.

A number of countries have also changed how deaths are calculated in recent weeks. The U.K. toll fell by more than 5,000 earlier this month after the government said a fatality would only be classed as Covid-related if the person died within 28 days of a positive test.


Since infections in most European countries began climbing only days or a few weeks ago, deaths could rise again too. Given the lag between infection and death, it’s important countries don’t develop a false sense of security, said Graham Cooke, a professor of infectious diseases at Imperial College London.

“There’s always a significant delay between a spike in cases and a spike in deaths, which is in the region of weeks,” said Cooke. “It’s possible that if more of the transmission early on is between younger groups that there will be more of a delay before we see the rise in mortality.”

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusEuropeCoronavirus TestsFranceGermanyAngela MerkelEurope economy

Next Story